Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-06

Clinical Trial Update: Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM) [NA]

View source ↗

Summary

A malaria-focused clinical trial in Zambia evaluating spatial repellent products has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Notre Dame | Conditions: Malaria | NA | Status: WITHDRAWN